Convalescent Plasma Randomized Clinical Trials for SARS-CoV-2 Prophylaxis and Early COVID-19 Treatment are Foundational for Subsequent Hyperimmune Globulin and Vaccines

Grant

Date/time Interval

  • June 1, 2020 - June 7, 2021
  • Total Award Amount

  • 2006132.00
  • Direct Costs

  • 1355187.00
  • Sponsor Award Id

  • Contributor

  • Edgar Overton   Investigator  
  • Marisa Marques   Investigator  
  • Paul Goepfert M.D.   Investigator  
  • Randall Davis M.D.   Investigator  
  • Sonya Heath   Principal Investigator  
  • Todd McCarty   Investigator